Profound Medical Corp.

PROF

Exchange: Nasdaq
Industry: Surgical & Medical Instruments & Apparatus
SEC CIK: 0001628808

SEC filings (opens in a new tab)

No open-market purchases or sales by Profound Medical Corp. insiders were filed in the last 90 days; 55 institutions reported holding it in 13F filings for Q2 2026, worth $105.8M in total; no superinvestor holds it.

Q4 2021 vs. Q3 2021

How the institutions holding Profound Medical Corp. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021 All holders in Q3 2021

13F holders of PROF: Q3 2021 compared with Q4 2021
Measure	Q3 2021	Q4 2021	Change
Holders	46	46	0
Shares	8.72M	9.78M	+1.05M (+12.1%)
Value	$127.6M	$109.8M	−$17.8M (−13.9%)

New holders (11)

Institutions that held Profound Medical Corp. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to PROF in Q4 2021
Institution	Shares	Value	% of portfolio
Timelo Investment Management Inc.	895,430	$10.1M	5.38%
National Bank of Canada	79,660	$722.0K	0.00%
Anson Funds Management LP	34,406	$388.0K	0.05%
Thompson Davis & Co., Inc.	33,138	$374.0K	0.31%
Harbor Advisors LLC	12,400	$139.0K	0.03%
Wolverine Trading, LLC	10,811	$128.0K	0.00%
D. E. Shaw & Co., Inc.	10,715	$121.0K	0.00%
UBS Group AG	1,428	$16.0K	0.00%
TD Waterhouse Canada Inc.	1,000	$13.5K	0.00%
Optiver Holding B.V.	340	$4.00K	0.00%
Tower Research Capital LLC (TRC)	263	$3.00K	0.00%

Sold out (11)

Institutions that held Profound Medical Corp. at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of PROF in Q4 2021
Institution	Shares, Q3 2021	Value, Q3 2021
Redmile Group, LLC	787,346	$11.5M
RTW Investments, LP	122,098	$1.79M
Marshall Wace, LLP	29,554	$433.0K
Millennium Management LLC	29,107	$426.0K
Two Sigma Advisers, LP	15,000	$220.0K
Chilton Investment Co LLC	10,000	$146.0K
CVI Holdings, LLC	10,000	$146.0K
Alpha Paradigm Partners, LLC	1,262	$18.0K
JPMorgan Chase & Co	202	$3.00K
Simplex Trading, LLC	217	$3.00K
Steward Partners Investment Advisory, LLC	200	$3.00K